We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Shortly after the U.S. Supreme Court agreed in June to hear Merck & Co.’s appeal in the years-long Fosamax liability litigation, acting Solicitor General Jefferey Wall asked for permission to present oral arguments.